757 Phase 1/2a clinical trial of BI-1808, a monoclonal antibody to tumor necrosis factor receptor 2 (TNFR2) as single agent and in combination with pembrolizumab

• Michael Chisamore,
• Jeffrey Yachnin,
• Ana Carneiro,
• Linda Mårtensson,
• Ingrid Teige,
• Björn Frendeus,
• Petra Holmkvist,
• Andres McAllister,
• Marie Borggren,
• Ingrid Karlsson,
• Mark Cragg,
• Lars Ny,
• Zsuzsanna Pápai,
• Kristoffer Staahl Rohrberg,
• Kirstie Cleary,
• Jan Anders Nilsson,
• Sean Lim,
• Johan E Wallin,
• Istvan Lang,
• Harriet Walter,
• Rikke H Lovendahl Eefsen,
• Edvard Abel,
• Robert Oldham,
• Susanne Gertsson

Affiliations

Michael Chisamore

4Merck and Co., Inc., Rahway, NJ, USA

Jeffrey Yachnin

1Karolinska Institutet, Stockholm, Sweden

Ana Carneiro

2Anesthesiology Department, Hospital de Dona Estefânia, Lisbon, Portugal

Linda Mårtensson

1BioInvent International, Lund, Sweden

Ingrid Teige

1BioInvent International, Lund, Sweden

Björn Frendeus

1BioInvent International, Lund, Sweden

Petra Holmkvist

1BioInvent International, Lund, Sweden

Andres McAllister

1BioInvent International, Lund, Sweden

Marie Borggren

1BioInvent International, Lund, Sweden

Ingrid Karlsson

1BioInvent International, Lund, Sweden

Mark Cragg

2University of Southampton, Southampton, UK

Lars Ny

Department of Oncology, Institute of Clinical Sciences, University of Gothenburg Sahlgrenska Academy, Goteborg, Sweden

Zsuzsanna Pápai

14MH Egészségügyi Központ Onkológiai, Budapest, Hungary

Kristoffer Staahl Rohrberg

8Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark

Kirstie Cleary

2University of Southampton, Southampton, UK

Jan Anders Nilsson

1BioInvent International, Lund, Sweden

Sean Lim

2University of Southampton, Southampton, UK

Johan E Wallin

3BioInvent, Lund, Sweden

Istvan Lang

4PRA Health Sciences, Budapest, Hungary

Harriet Walter

2University of Leicester and University Hospitals of Leicester NHS Trust, -, Leicester, UK

Rikke H Lovendahl Eefsen

8Herlev Hospital, Herlev, Denmark

Edvard Abel

7Sahlgrenska University Hospital, Gothenburg, Sweden

Robert Oldham

6University of Southampton, Southampton, UK

Susanne Gertsson

10BioInvent International, Lund, Sweden